Evaluating Transduction Efficiency in Human Macrophages Using HIV-1 Lentiviral Vectors
Author Information
Author(s): Francisco J Leyva, Joshua J Anzinger, J Philip McCoy Jr, Howard S Kruth
Primary Institution: National Heart, Lung, and Blood Institute, NIH, Bethesda, MD, USA
Hypothesis
The study aims to determine the transduction efficiency of two HIV-based lentiviral vector configurations for primary human blood monocyte-derived macrophages.
Conclusion
The study found that VSV-G pseudotyped HIV-based lentiviral vectors can efficiently transduce human blood monocyte-derived macrophages early during differentiation without interfering with the differentiation process.
Supporting Evidence
- Transduction efficiency was maximal at an MOI of 10 for VRX1090, ranging between 80 and 90%.
- Transduction efficiency was maximal at an MOI of 25 to 50 for VRX494, ranging between 58 and 67%.
- Transducing monocyte-derived macrophages with VRX1090 lentivirus using an MOI of 10 consistently gives 80-90% transduction efficiency.
Takeaway
Scientists tested two types of viruses to see how well they could deliver genes into special immune cells called macrophages, and they found that one type worked really well if used early.
Methodology
Human blood monocytes were differentiated into macrophages and transduced with two HIV-based lentiviral vectors at various times and multiplicities of infection, with efficiency assessed using fluorescence microscopy and flow cytometry.
Potential Biases
Potential donor variability may affect transduction efficiency results.
Limitations
The study did not explore the long-term effects of transduction on macrophage function or the potential risks associated with using lentiviral vectors.
Participant Demographics
Human blood monocytes were collected from three healthy blood donors.
Statistical Information
P-Value
0.013
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website